People v. Cole

• Decision Date: 19 February 2014
• Citation: 980 N.Y.S.2d 551,2014 N.Y. Slip Op. 01182,114 A.D.3d 869
• Parties: The PEOPLE, etc., respondent, v. Roger COLE, appellant.
• Court: New York Supreme Court — Appellate Division

114 A.D.3d 869

980 N.Y.S.2d 551

2014 N.Y. Slip Op. 01182

The PEOPLE, etc., respondent,

v.Roger COLE, appellant.

Supreme Court, Appellate Division, Second Department, New York.

Feb. 19, 2014.

Lynn W.L. Fahey, New York, N.Y. (De Nice Powell of counsel), for appellant, and appellant pro se.

Kenneth P. Thompson, District Attorney, Brooklyn, N.Y. (Leonard Joblove, Thomas M. Ross, and Claibourne Henry of counsel), for respondent.

WILLIAM F. MASTRO, J.P., LEONARD B. AUSTIN, SANDRA L. SGROI, and ROBERT J. MILLER, JJ.

Appeal by the defendant from a resentence of the Supreme Court, Kings County (Marrus, J.), imposed January 20, 2012, pursuant to the Drug Law Reform Act of 2004 (L. 2004, ch. 738), the resentence being five determinate terms of imprisonment of 20 years to be followed by a 5–year period of postrelease supervision on each of those terms, upon his convictions, after a jury trial, of criminal sale of a controlled substance in the first degree (five counts), with those terms of imprisonment to run consecutively to each other and concurrently with an indeterminate term of imprisonment of 1 1/3 to 4 years previously imposed by judgment of the same court rendered July 7, 1992, upon his conviction of criminal sale of a firearm in the second degree.

ORDERED that the resentence is modified, as a matter of discretion in the interest of justice, by reducing the resentence imposed from five determinate terms of imprisonment of 20 years followed by a 5–year period of postrelease supervision on each of those terms to five determinate terms of imprisonment of 15 years followed by a 5–year period of postrelease supervision on each of those terms.

In 1992, the defendant was convicted, after a jury trial, of five counts of criminal sale of a controlled substance in the first degree ( seePenal Law § 220.21), and one count of criminal sale of a firearm in the second degree ( seePenal Law § 265.11). The defendant was sentenced to five indeterminate terms of imprisonment of 25 years to life for the convictions of criminal sale of a controlled substance in the first degree and one indeterminate term of imprisonment of 1 1/3 to 4 years for the conviction of criminal sale of a firearm in the second degree. The terms of imprisonmentfor the convictions of criminal sale of a controlled substance in the first degree were directed to run consecutively to each other and concurrently with the term of imprisonment imposed for the conviction of criminal sale of a firearm in the second degree, for a total aggregate term of imprisonment of 125 years to life.

In 2011, the defendant moved to be resentenced pursuant to the Drug Law Reform Act of 2004 (L. 2004, ch. 738, § 23; hereinafter the DLRA). The Supreme Court granted the defendant's motion to the extent of resentencing him, for the five convictions of criminal sale of a controlled substance in the first degree, to five determinate terms of imprisonment of 20 years, to run consecutively to each other and concurrently with the sentence originally imposed on the conviction of criminal sale of a firearm in the second degree, for a total aggregate determinate term of imprisonment of 100 years. The defendant appeals, contending that the resentence is excessive and that the Supreme Court should have resentenced him, for the convictions of criminal sale of a controlled substance in the first degree, to five determinate terms of imprisonment of 15 years. The defendant also contends, in his pro se supplemental brief, that the Supreme Court should have directed that the resentences should run concurrently with each other.

The general purpose of the DLRA was to provide ameliorative relief by reducing the sentences of eligible individuals who were sentenced under the relatively higher mandatory minimum terms of imprisonment dictated by the indeterminate sentencing scheme of the Rockefeller Drug Laws ( see People v. Yusuf, 19 N.Y.3d 314, 320, 947 N.Y.S.2d 399, 970 N.E.2d 422;People v. Sosa, 18 N.Y.3d 436, 438, 940 N.Y.S.2d 534, 963 N.E.2d 1235;People v. Utsey, 7 N.Y.3d 398, 401, 822 N.Y.S.2d 475, 855 N.E.2d 791;People v. Lashley, 83 A.D.3d 868, 869, 920 N.Y.S.2d 421). Accordingly, when the Legislature enacted the DLRA in 2004, it “eliminated the mandatory minimum 15–year to life sentences for class A–I drug offenders ( see Penal Law former § 70.00[2][a]; [3][a][i] ), ... and replaced the indeterminate sentencing structure with determinate sentences” ( People v. Duke, 40 A.D.3d 872, 873, 836 N.Y.S.2d 263;seePenal Law §§ 70.00[1]; 70.71; People v. Utsey, 7 N.Y.3d at 401, 822 N.Y.S.2d 475, 855 N.E.2d 791). The DLRA also contained a provision which allowed individuals convicted of a class A–I felony committed before the effective date of the new law to move for resentencing in accordance with the new determinate sentencing scheme ( see L. 2004, ch. 738, § 23 [eff. December 27, 2004] ).

Here, the defendant sought to be resentenced for the convictions of criminal sale of a...